Skip to main content

Table 1 Correlation of tumor MTSS1 mRNA expression level with clinicopathological parameters of HCC patients

From: Elevated MTSS1 expression associated with metastasis and poor prognosis of residual hepatitis B-related hepatocellular carcinoma

Clinicopathological parameters Number MTSS1/GAPDH mRNA (n) P
MTSS1-low group MTSS1-high group
(≤0.18, n = 17) (>0.18, n = 20)
Age 37    0.900
  ≤ 52 y 20 9 11  
  > 52 y 17 8 9  
Sex 37    0.588
 Female 8 3 5  
 Male 29 14 15  
Cirrhosis 37    0.855
 Yes 30 14 16  
 No 7 3 4  
Tumor number 37    0.035*
 Multiple 20 6 14  
 Single 17 11 6  
Satellite 36a    0.019*
 Yes 15 3 12  
 No 21 13 8  
Tumor size, cm 37    0.212
  ≤ 5 7 5 2  
  > 5 30 12 18  
Encapsulation 37    0.008**
 Complete 15 11 4  
 Incomplete or none 22 6 16  
Vascular invasion 36a    0.042*
 Yes 21 6 15  
 No 15 11 4  
TNM stage 37    0.033*
 Early stage (II) 7 6 1  
 Advanced stage (III-IVA) 30 11 19  
AFP level, ng/mL 37    0.036*
  ≤ 20 11 2 9  
  > 20 26 15 11  
γ-Glutamyl transferase, units/L 37    0.134
  ≤ 54 19 11 8  
  > 54 18 6 12  
Adjuvant TACE 37    0.815
 Yes 16 7 9  
 No 21 10 11  
  1. NOTE: HCC hepatocellular carcinoma, TACE transcatheter arterial chemoembolization
  2. Significant difference: * < 0.05, ** < 0.01
  3. aNumber less than 37 due to missing data